Preclinical efficacy and mechanisms of statin-loaded polymeric nanocapsules: a meta-analysis of tumor lipid metabolism inhibition
8.5
来源：
Nature
关键字：
LNP
发布时间：
2025-11-03 23:51
摘要：
Statin-loaded polymeric nanocapsules have shown significant antitumor efficacy by enhancing the bioavailability and stability of statins, as evidenced by a meta-analysis of 22 preclinical studies. The findings indicate that these nanocapsules can effectively inhibit tumor growth and weight across various solid tumor models. The study emphasizes the potential of nanomedicine in cancer therapy, particularly for tumors reliant on lipid metabolism, and calls for future clinical trials to further explore their applicability.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分
business_impact
0.8分
scientific_rigor
1.5分
timeliness_innovation
1.5分
investment_perspective
2.5分
market_value_relevance
1.0分
team_institution_background
0.5分
technical_barrier_competition
0.5分
关键证据
Statin-loaded polymeric nanocapsules significantly inhibited tumor growth (SMD −1.79; p < 0.00001).
The meta-analysis included 22 preclinical studies with a total of 127 animals.
Future clinical trials are needed to validate these preclinical results.
真实性检查
否
AI评分总结
Statin-loaded polymeric nanocapsules have shown significant antitumor efficacy by enhancing the bioavailability and stability of statins, as evidenced by a meta-analysis of 22 preclinical studies. The findings indicate that these nanocapsules can effectively inhibit tumor growth and weight across various solid tumor models. The study emphasizes the potential of nanomedicine in cancer therapy, particularly for tumors reliant on lipid metabolism, and calls for future clinical trials to further explore their applicability.